MyChesCo on MSN27m
Mineralys Therapeutics Receives FDA Clearance for Phase 2 Trial of Lorundrostat in Treating Sleep Apnea and HypertensionRADNOR, PA — Mineralys Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback